Keystone Symposia
Home | My Account | Shopping Cart  0
  Advanced
     facebook  twitter
Please note: All programs are subject to change. Check this site for updates.

Continuing Medical Education (CME) credits no longer available.

Joint meeting: Diabetes (Z6) (Registration for one meeting allows attendance at either meeting, pending space availability.)
Download Meeting Flyer



LANGUAGE NOTE: This meeting will be conducted in English.
Register YourselfRegister a Colleague


Meeting Program

To view program in "24 hour" time (international) click here.


Monday, April 12
3:00 - 7:30 PM Registration Foyer
6:30 - 7:30 PM Refreshments Foyer
7:15 - 7:30 PM Orientation
7:30 - 9:30 PM Keynote Session (Joint)
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B,C
Victor Ambros, University of Massachusetts, USA
MicroRNAs in Model Systems and Human Disease
Jennifer A. Lippincott-Schwartz, National Institutes of Health, USA
Mitochondrial Role in Cell Cycle Control and Autophagy
Tuesday, April 13
7:00 - 8:00 AM Breakfast Sea to Sky Ballroom A, Lower Level
8:00 - 11:00 AM From Stem Cell Development to Transplantation
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B
Bernhard J. Hering, University of Minnesota, USA
Islet Transplantation: Today and Tomorrow
Anne Grapin-Botton, Ecole Polytechnique Fédérale De Lausanne, Switzerland
Role of Pancreas 3D Architecture in Endocrine Cell Development
Speaker to be Announced,
Maike Sander, University of California, San Diego, USA
Control of Cell Fate Choice in the Pancreas
Following Session is for Diabetes (Z6)
8:00 - 11:00 AM Genetics of Diabetes
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom C
Philippe Froguel, Imperial College of London, UK
Genome Structure and Point DNA Variation: The Power of the Extreme in Diabesity
Mark McCarthy, University of Oxford, UK
Type 2 Diabetes: Susceptibility Variants across the Allele Frequency Spectrum
Jose C. Florez, Massachusetts General Hospital, USA
Genetic Epidemiology of T2D and Related Traits in General Populations
Eric Schadt, Pacific Biosciences, USA
Multi-Tissue Networks Elucidate T2D Circuits
Jussi A. Pihlajamäki, Kuopio University Hospital, Finland
Short Talk: Alternative Splicing is Regulated by Weight Loss and Differs between Fat Depots in Humans
Jeremy B.M. Jowett, Baker IDI Heart and Diabetes Institute, Australia
Short Talk: Expression Profiling Identifies Biomarkers for Progression to Type 2 Diabetes
9:20 - 9:40 AM Coffee Break Foyer
11:00 AM- On Own for Lunch and Recreation
11:00 AM- 1:00 PM Poster Setup Foyer/Mountain View/Sea to Sky Ballroom A
1:00 - 10:00 PM Poster Viewing Foyer/Mountain View/Sea to Sky Ballroom A
4:30 - 5:00 PM Coffee Available Foyer
5:00 - 7:00 PM Signaling in Pancreatic B-Cells
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B
Eckhard Lammert, Heinrich-Heine-University of Duesseldorf, Germany
Role of Blood Vessels in Pancreatic Islet Development and Function
Marc A. Prentki, CRCHUM/ University of Montreal, Canada
Beta Cell Metabolic Signaling and Dysfunction in Type 2 Diabetes
Ingo B. Leibiger, Karolinska Institutet, Sweden
Insulin Signaling in the Pancreatic Beta Cell
Following Session is for Diabetes (Z6)
5:00 - 7:00 PM Cell and Tissue Signaling Mechanisms in Diabetes
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom C
Claire Bastie, Albert Einstein College of Medicine, USA
Fyn-Dependent Regulation of Energy Expenditure and Body Weight is Mediated by Tyrosine Phosphorylation of LKB1
Robert E. Lewis, University of Nebraska Medical Center, USA
Molecular Scaffolds as Energy Sensors
Bei B. Zhang, Merck Research Laboratories, USA
Modulation of Glucose, Amino Acid and Lipid Metabolism Pathways with Pharmacological Agents
Philipp Gut, University of California San Francisco, USA
Short Talk: In vivo Drug Discovery of New Regulators of Glucose Metabolism using Transgenic “Gluconeogenesis Reporter” Zebrafish
7:00 - 8:00 PM Social Hour w/ Lite Bites Foyer/Mountain View/Sea to Sky Ballroom A
7:30 - 10:00 PM Poster Session 1
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Foyer/Mountain View/Sea to Sky Ballroom A
Wednesday, April 14
7:00 - 8:00 AM Breakfast Sea to Sky Ballroom A, Lower Level
8:00 - 11:00 AM Transcriptional Networks Signaling
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B
Doris A. Stoffers, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, USA
Pdx1 Partners and Targets in Beta Cell Development and Function
Markus Stoffel, Institut f. Molekulare Systembiologie, Switzerland
MicroRNA Networks
Wilhelm Krek, ETH Zurich, Switzerland
HIF Signaling in Beta Cells
Alan D. Attie, University of Wisconsin-Madison, USA
Networks of QTLs, mRNAs, and microRNAs in Beta Cell Growth and Function
Short Talk(s) to be Chosen from Abstracts,
Following Session is for Diabetes (Z6)
8:00 - 11:00 AM Intertissue Communication
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom C
Barbara B. Kahn, Beth Israel Deaconess Medical Center, USA
A Novel Pathway in Adipose Tissue and Liver that Regulates Adiposity
Kenneth Walsh, Boston University School of Medicine, USA
Discovery of Novel Myokines
Philipp E. Scherer, University of Texas Southwestern Medical Center, USA
Discovery of Novel Adipokines
Fatima Bosch, Universitat Autonoma Barcelona, Spain
Gene Therapy and Diabetes
David B. Briggs, University of Arizona, USA
Short Talk: Inhibition of Adiponectin Oligomerization under Oxidizing Conditions and Induction of an Oxidizing Redox Environment in Endoplasmic Reticulum of 3T3-L1 Adipocytes Exposed to High Concentrations of Palmitate
Marianna Sadagurski, Childrens Hospital, Harvard Medical School, USA
Short Talk: Inactivation of Foxo1 in Leptin Receptor (LepRb)-Expressing Neurons Reverses Obesity and Diabetes, Caused by Deletion of Insulin Receptor Substrate 2 (Irs2)
9:20 - 9:40 AM Coffee Break Foyer
11:00 AM- On Own for Lunch and Recreation
11:00 AM- 1:00 PM Poster Setup Foyer/Mountain View/Sea to Sky Ballroom A
1:00 - 10:00 PM Poster Viewing Foyer/Mountain View/Sea to Sky Ballroom A
4:30 - 5:00 PM Coffee Available Foyer
5:00 - 7:00 PM Molecular Mechanisms in Insulin Secretion and Action (Joint)
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B,C
C. Ronald Kahn, Joslin Diabetes Center, USA
Insulin Signaling and Insulin Resistance: The Ultimate Systems Biology Problem
Per-Olof Berggren, Karolinska Institutet, Sweden
Systems Biology Approach to Study Beta Cell Function and Survival
Morris J. Birnbaum, University of Pennsylvania, USA
The Role of Akt in the Regulation of Hepatic Metabolism by Insulin
Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM Social Hour w/ Lite Bites Foyer/Mountain View/Sea to Sky Ballroom A
7:30 - 10:00 PM Poster Session 2
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Foyer/Mountain View/Sea to Sky Ballroom A
Thursday, April 15
7:00 - 11:00 AM Poster Setup Foyer/Mountain View/Sea to Sky Ballroom A
7:00 - 8:00 AM Breakfast Sea to Sky Ballroom A, Lower Level
8:00 - 11:00 AM Control of Insulin Secretory Machinery in Diabetes
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B
Patrik Rorsman, Oxford Centre for Diabetes, Endocrinology and Metabolism, UK
Calcium Channels and Insulin Exocytosis
Michele Solimena, Dresden University of Technology, Germany
Signaling from the Insulin Granule to the Nucleus
Gerard Karsenty, Columbia University Medical Center, USA
Regulation of Glucose Homeostasis by Osteocalcin
Herbert Y. Gaisano, University of Toronto, Canada
Molecular Mechanism of Insulin Granule-Granule Fusion Contributing to Biphasic Insulin Secretion
Following Session is for Diabetes (Z6)
8:00 - 11:00 AM Inflammatory Mechanisms and Insulin Resistance
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom C
Diane J. Mathis, Harvard Medical School, USA
Lymphocyte Regulation of Adipose Tissue Inflammation
Roger J. Davis, University of Massachusetts Medical School, USA
Pathogenesis Mechanisms of the JNK Pathway
Remy G. Burcelin, Institute of Molecular Medicine, France
Intestinal Microflora, Inflammation, and Metabolic Diseases
Michael P. Czech, University of Massachusetts Medical School, USA
RNAi-Based Strategies to Address Metabolic Dysfunction
Birgitte Lindegaard, Centre of Inflammation and Metabolism, Rigshospitalet, Denmark
Short Talk: IL-18 Increases Intramuscular Fat Oxidation by Activating AMPK
Heather C. Denroche, University of British Columbia, Canada
Short Talk: Leptin Therapy Reverses Fasting Hyperglycemia and Enhances Insulin Sensitivity in Diabetic Mice, Independent of Hepatic Leptin Signalling
9:20 - 9:40 AM Coffee Break Foyer
11:30 AM- 12:30 PM Lunch
12:30 - 2:30 PM Poster Session 3
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Foyer/Mountain View/Sea to Sky Ballroom A
4:30 - 5:00 PM Coffee Available Foyer
5:00 - 7:00 PM Emerging Targets for Improving Insulin Action and Secretion (Joint)
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B,C
Richard D. Dimarchi, Indiana University, USA
Novel Glucagon-Like Chimera Peptides – Virtues of Combinatorial Pharmacology
David E. Moller, Eli Lilly and Company, USA
Challenges and Opportunities for Diabetes Drug Discovery
Johan Auwerx, Ecole Polytechnique Federale de Lausanne, Switzerland
Integrating Metabolic Control by NAD+ Sensors
7:00 PM- On Own for Dinner Foyer/Mountain View/Sea to Sky Ballroom A
Friday, April 16
7:00 - 8:00 AM Breakfast Sea to Sky Ballroom A, Lower Level
8:00 - 11:00 AM Insulin Secretion and Action in Humans (Joint)
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B,C
Andrew Hattersley, Peninsula Medical School, UK
Learning from Genetic Beta Cell Defects in Man
Anna Moore, Massachusetts General Hospital, USA
Imaging Pancreatic Islets in vivo: Current Status
Juleen R. Zierath, Karolinska Institutet, Sweden
Insulin Action in Human Skeletal Muscle
Peter Arner, Karolinska Institute, Sweden
Dysfunction in Human Adipose Tissue and Insulin Resistance
Short Talk(s) to be Chosen from Abstracts,
9:20 - 9:40 AM Coffee Break Foyer
11:00 AM- On Own for Lunch and Recreation
4:30 - 5:00 PM Coffee Available Foyer
5:00 - 7:00 PM Beta Cell Stress in Diabetes
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom B
Marc Y. Donath, Universitätsspital Zürich, Universität Zürich, Switzerland
Islet Inflammation in Type 2 Diabetes: Novel Mechanisms and Treatment
Thomas Mandrup-Poulsen, Hagedorn Research Institute, Denmark
Cytokine Signaling in Inflammatory beta-Cell Destruction
Rohit N. Kulkarni, Joslin Diabetes Center, USA
Insulin/IGF-I Signaling, Mitochondrial Function and Endoplasmic Stress in Pancreatic beta-Cells
Short Talk to be Chosen from Abstracts,
Following Session is for Diabetes (Z6)
5:00 - 7:00 PM Type 2 Diabetes in Children and Adolescents
Registered attendees for this meeting can view Abstracts for this session starting on 03/12/2010
Sea to Sky Ballroom C
Rebecca Anne Simmons, University Pennsylvania School of Medicine, USA
Epigenetic Mechanisms in the Development of Type 2 Diabetes
Susan Ozanne, University of Cambridge, UK
Early Life Programming of Type 2 Diabetes
Phil Zeitler, University of Colorado Denver, USA
Type 2 Diabetes in Children and Adolescents: Epidemiology, Pathophysiology, and Comorbidities
Kasper Rud†, Faculty of Health Sciences, Denmark
Short Talk: Effects of Gestational Low Protein Diet Followed by Postnatal High Fat or High Sucrose Diet on the Interplay between Fat and Carbohydrate Metabolism in Rat Mitochondria
7:00 - 8:00 PM Social Hour w/ Lite Bites Foyer/Mountain View/Sea to Sky Ballroom A
8:00 - 11:00 PM Entertainment Foyer/Mountain View/Sea to Sky Ballroom A
Saturday, April 17
Departure
      *=Session Chair     †=Speaker invited, not yet responded.



Keystone Symposia would like to thank the sponsors of this meeting for their generous support:

We gratefully acknowledge additional support for this conference from:




The Directors' Fund

These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.

We gratefully acknowledge the generous grants for this conference provided by:

National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
National Institute on Aging (NIA)
Grant No. 1R13DK084688-01


The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge the organizations that provide Keystone Symposia with additional support, such as marketing and advertising...

Click here to view these companies

This symposium will focus on advances in our understanding of normal pancreatic b-cell function and mechanisms of beta-cell failure in type 2 diabetes, which has become a pandemic disease with estimates of affected individuals reaching 350 millions in 2030. Defects in pancreatic b-cell function and reduced beta cell mass are now recognized as the event that triggers the transition from pre-diabetes/metabolic syndrome to overt type 2 diabetes. Major advances have been made in our understanding of fundamental beta-cell biology, signaling pathways regulating islet growth, apoptosis, regeneration in normal and disease states, and development of new strategies for enhancing beta-cell survival and function. Leading contributors of academic and industrial contributors alike will carefully discuss recent advances in several disciplines, including development, regeneration, stem cells, transcription factors, novel signaling pathways, cell biology, genetics, gene regulation, drug targeting, as well as emerging technologies in islet research.